Polaris Financial Partners Makes New $1.07 Million Investment in Global X Genomics & Biotechnology ETF $GNOM

by · The Markets Daily

Polaris Financial Partners bought a new stake in shares of Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 15,041 shares of the company’s stock, valued at approximately $1,067,000. Polaris Financial Partners owned approximately 1.03% of Global X Genomics & Biotechnology ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

Separately, Bank of America Corp DE increased its position in Global X Genomics & Biotechnology ETF by 67.8% in the first quarter. Bank of America Corp DE now owns 119,795 shares of the company’s stock worth $5,240,000 after buying an additional 48,394 shares in the last quarter. Institutional investors and hedge funds own 56.95% of the company’s stock.

Global X Genomics & Biotechnology ETF Stock Performance

Shares of NASDAQ GNOM traded up $0.84 during trading on Friday, hitting $69.62. The company had a trading volume of 16,757 shares, compared to its average volume of 19,110. Global X Genomics & Biotechnology ETF has a 12 month low of $40.17 and a 12 month high of $71.10. The firm has a market capitalization of $101.65 million, a P/E ratio of -29.75 and a beta of 1.17. The stock has a 50 day simple moving average of $62.76 and a 200 day simple moving average of $53.68.

Global X Genomics & Biotechnology ETF Company Profile

(Free Report)

Complete Genomics, Inc is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center.

See Also

Want to see what other hedge funds are holding GNOM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global X Genomics & Biotechnology ETF (NASDAQ:GNOM – Free Report).